$129.58
-1.74
(-1.33%)
As of Sep 5, 2026, 10:47 AM EDT
Price history
Novartis (NOVN) is trading down at $129.58 (-1.33%) on Europe, as of the latest quote. It is a Europe constituent in the Health Care sector.
IPO: September 21, 2016 · $11.00 offering · NASDAQ · View IPO details →
About Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Recent News (15)
-
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced an update on Novartis’ Phase 3 results from the HORIZON outcomes trial for pelacarsen, an antisense oli…
-
Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) Ad hoc announcement pursuant to Art. 53 LR
-
Novartis stock holds steady as billion-dollar Alteogen deal and MS pill data reshape pipeline Novartis stock holds steady as billion-dollar Alteogen deal and MS pill data reshape pipeline AD HOC NEWS
-
Novartis could cut about 130 jobs in Basel site relocation Novartis could cut about 130 jobs in Basel site relocation Reuters
-
-
Novartis stock rises after MS drug remibrutinib trial results Novartis stock rises after MS drug remibrutinib trial results Yahoo Finance
-
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the ex…
-
Novartis stock gains after MS pill trial success despite cell therapy setback Novartis stock gains after MS pill trial success despite cell therapy setback AD HOC NEWS
-
-
Stocks making the biggest moves premarket: Nvidia, Robinhood, Novartis & more Stocks making the biggest moves premarket: Nvidia, Robinhood, Novartis & more CNBC
-
Why is Novartis stock surging today?
Why is Novartis stock surging today?
-
Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials Ad hoc announcement pursuant to Art. 53 LR
-
Stocks to Watch: GM, BAE Systems, Novartis, Swatch Stocks to Watch: GM, BAE Systems, Novartis, Swatch
-
Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth
-
More Health Care stocks
- BMY Bristol Myers Squibb
- JNJ Johnson & Johnson
- LLY Lilly (Eli)
- MRK Merck & Co.
- PFE Pfizer
- VTRS Viatris
- ZTS Zoetis
- A Agilent Technologies